Carriers of APOE ε4 and GBA mutations had faster cognitive decline and were at higher risk of progression to dementia [116], whereas no significant gene-related effects were observed for MAPT and SNCA rs356219 [117]. The gene discussed is APOE; the disease is Mental deterioration.